Eurofins Scientific SE
PAR:ERF
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
44.19
61.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Eurofins Scientific SE
Operating Margin
Eurofins Scientific SE
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | LU |
| Market Cap | 9.1B EUR |
| Operating Margin |
14%
|
| Country | US |
| Market Cap | 1.3T USD |
| Operating Margin |
14%
|
| Country | US |
| Market Cap | 196.2B USD |
| Operating Margin |
17%
|
| Country | US |
| Market Cap | 170.9B USD |
| Operating Margin |
21%
|
| Country | KR |
| Market Cap | 67.8T KRW |
| Operating Margin |
31%
|
| Country | CH |
| Market Cap | 38.5B CHF |
| Operating Margin |
13%
|
| Country | US |
| Market Cap | 38.6B USD |
| Operating Margin |
25%
|
| Country | US |
| Market Cap | 36.5B USD |
| Operating Margin |
14%
|
| Country | US |
| Market Cap | 26.7B USD |
| Operating Margin |
28%
|
| Country | US |
| Market Cap | 23.2B USD |
| Operating Margin |
20%
|
| Country | US |
| Market Cap | 23B USD |
| Operating Margin |
29%
|
Eurofins Scientific SE
Glance View
Eurofins Scientific SE is a global leader in bio-analytical testing, offering a broad array of laboratory services that cater to a variety of sectors including food, pharmaceuticals, environmental, and consumer products. Founded in 1987, the company has expanded rapidly through strategic acquisitions and organic growth, positioning itself as a crucial partner for businesses aiming to ensure quality and compliance in their products. With its presence in over 50 countries and a workforce exceeding 50,000, Eurofins operates a network of highly specialized laboratories that leverage cutting-edge technology to deliver accurate, reliable testing services. Investors will appreciate the company’s robust growth trajectory, underpinned by a diverse customer base and an increasing global demand for testing services amid rising regulatory scrutiny. As the world continues to grapple with health and safety challenges, Eurofins is poised to benefit from heightened awareness around food safety, environmental sustainability, and pharmaceutical integrity. The company’s commitment to innovation — investing significantly in research and development as well as state-of-the-art technology — ensures it remains at the forefront of scientific advancements. By focusing on quality assurance and risk assessment, Eurofins not only safeguards public health but also enhances the integrity of its clients’ products. For investors, Eurofins presents an attractive growth opportunity, with its solid operational foundations, strategic acquisitions, and resilience in navigating global markets making it a compelling addition to any investment portfolio.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Eurofins Scientific SE's most recent financial statements, the company has Operating Margin of 14%.
You don't have any saved screeners yet
